Skip to search.
 FTSE 100 Up 0.90%

Achillion Pharmaceuticals, Inc. (ACHN)

-NasdaqGS
7.39 Down 0.37(4.77%) 31 Aug 21:00
|After Hours: : 7.39 Down 0.00 (0.04%) 21:40
Add to Portfolio
Prev Close:7.76
Open:7.74
Bid:7.40 x 5000
Ask:8.46 x 2500
1y Target Est:14.86
Beta:2.03761
Earnings Date:2 Nov - 6 Nov (Est.)
Day's Range:7.37 - 7.87
52wk Range:6.71 - 16.87
Volume:2,005,422
Avg Vol (3m):2,655,400
Market Cap:1.01b
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ACHN at this time.

Comparison

Symbol% ChgMkt Cap
ACHNDown 4.77%1.01b
GSKDown 0.78%98.93b
JNJDown 1.25%260.24b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,488.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.36
Quarterly EPS Est (Sep-15) :0.01
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback